Rivian shelving Mercedes-Benz JV is a ‘head-scratcher:’ analyst
Rivian’s (NASDAQ: RIVN) decision to shelf a joint venture to develop electric vans is a “head-scratcher,” one analyst said, as the two companies signed a Memorandum of Understanding (MOU) just three months ago.
This morning, Rivian announced its plans to “no longer pursue” the MOU it signed with Germany’s Mercedes-Benz to build EV vans. Citing its decision to prioritize near-term goals through a focus on its consumer and already-established commercial market, Rivian said pausing the plans would hopefully culminate in future collaboration.
“As we evaluate growth opportunities, we pursue the best risk-adjusted returns on our capital investments. At this point in time, we believe focusing on our consumer business, as well as our existing commercial business, represent the most attractive near-term opportunities to maximize value for Rivian,” CEO RJ Scaringe said in a statement.
Rivian signed the MOU with Mercedes-Benz in September.
However, analysts are baffled by the decision. Wedbush’s Dan Ives said the only-three-month-old joint venture already being shelved is on par for 2022, but the decision was still a “head-scratcher.”
“This is a complete head-scratcher that Rivian scraps the deal three months after a major announcement,” Ives told Teslarati in a statement. “Never seen anything like this, but then again, it’s a twilight zone in 2022, so nothing is off the table.”
Ives holds a $37 price target on Rivian and maintains a ‘Buy’ rating on the stock. He once said the automaker was undoubtedly a “long-term winner,” but the company needed to “stop the excuses” for not delivering units to customers. Since then, Rivian has ramped production to more acceptable levels. In Q3, it produced 7,363 and delivered 6,584 vehicles.
The length of the Rivian – Mercedes-Benz partnership is intriguing. In a single quarter, Rivian has gone from committing to an MOU to scrapping the joint venture plans for the near term.
In Q3, the automaker reported $536 million in revenues, while analysts expected $551.6 million. The company did report a smaller loss per share than expected at $1.57. Analysts expected a loss of $1.82 per share. The automaker said it was confident its $13.8 billion in cash on hand, which was down from $15.5 billion at the end of Q2, would last the company through 2025.
Automotive startups have felt incredible pressure through the past few years due to supply chain bottlenecks and other consequences due to the COVID-19 pandemic. Rivian, along with other companies attempting to ramp production during the last few years, has experienced financial strain and incredible challenges due to the market. The automaker said it would focus on its consumer and commercial markets before exploring additional opportunities.
Disclosure: Joey Klender is not a RIVN Shareholder.
I’d love to hear from you! If you have any comments, concerns, or questions, please email me at [email protected]. You can also reach me on Twitter @KlenderJoey, or if you have news tips, you can email us at [email protected].
The post Rivian shelving Mercedes-Benz JV is a ‘head-scratcher:’ analyst appeared first on TESLARATI.
Source: https://www.teslarati.com/rivian-rivn-mercedes-benz-joint-venture-dan-ives-head-scratcher/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.